Beranda › Kolitis Ulseratif › South Carolina › Greenville
Uji klinis Kolitis Ulseratif di Greenville, SC
5 studi untuk Kolitis Ulseratif mencari peserta di lokasi sekitar Greenville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Menerima pesertaFase 3
- Patewood Medical Campus /ID# 272477, Greenville
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Menerima pesertaFase 3
- Gastroenterology Associates - Patewood, Greenville
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Menerima pesertaFase 2
- Gastroenterology Associates, P.A. of Greenville, Greenville
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Menerima pesertaFase 2
- Mirador Therapeutics Selected Site, Greenville
Uji klinis Kolitis Ulseratif di kota lain
- New York City, NY23 studi
- Orlando, FL22 studi
- Miami, FL21 studi
- Houston, TX17 studi
- San Antonio, TX16 studi
- Tyler, TX15 studi
- Tacoma, WA15 studi
- Chicago, IL15 studi
- San Diego, CA15 studi
- Colorado Springs, CO14 studi
- St. Louis, MO13 studi
- Los Angeles, CA13 studi
Studi lain di Greenville
- Kanker Paru Non-Sel Kecil15 studi
- Kanker Payudara12 studi
- Leukemia Mieloid Akut10 studi
- Kanker (semua jenis)9 studi
- Obesitas9 studi
- Kanker Paru9 studi
- Kelebihan Berat Badan8 studi
- Kanker Prostat7 studi
- Kanker Kolorektal7 studi
- Kanker Lambung6 studi
- Penyakit Arteri Perifer5 studi
- Limfoma Burkitt5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.